Page last updated: 2024-10-25

dantrolene and Obesity, Morbid

dantrolene has been researched along with Obesity, Morbid in 1 studies

Dantrolene: Skeletal muscle relaxant that acts by interfering with excitation-contraction coupling in the muscle fiber. It is used in spasticity and other neuromuscular abnormalities. Although the mechanism of action is probably not central, dantrolene is usually grouped with the central muscle relaxants.
dantrolene : The hydrazone resulting from the formal condensation of 5-(4-nitrophenyl)furfural with 1-aminohydantoin. A ryanodine receptor antagonist used for the relief of chronic severe spasticity and malignant hyperthermia.

Obesity, Morbid: The condition of weighing two, three, or more times the ideal weight, so called because it is associated with many serious and life-threatening disorders. In the BODY MASS INDEX, morbid obesity is defined as having a BMI greater than 40.0 kg/m2.

Research Excerpts

ExcerptRelevanceReference
" Current dantrolene dosing recommendations are based on actual body weight despite a paucity of literature in obese patients."1.46Malignant Hyperthermia in a Morbidly Obese Patient Depletes Community Dantrolene Resources: A Case Report. ( Gamble, J; Magistris, F, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Magistris, F1
Gamble, J1

Other Studies

1 other study available for dantrolene and Obesity, Morbid

ArticleYear
Malignant Hyperthermia in a Morbidly Obese Patient Depletes Community Dantrolene Resources: A Case Report.
    A & A case reports, 2017, Nov-01, Volume: 9, Issue:9

    Topics: Adult; Carcinoid Tumor; Dantrolene; Duodenal Neoplasms; Female; Humans; Malignant Hyperthermia; Musc

2017